Abstract
This study aimed to identify which graft product subset of cells might be the most predictive of late haematopoietic recovery (three to 12 months) following autologous peripheral blood stem cell transplantation (PBSCT). The relationships between the numbers of reinfused CD34+ cells and their immature subsets such as CD34+/CD90+, CD34+/AC133+, CD34+/CD38- and CD34+/HLA-DR- cells, and haemoglobin, white blood cell (WBC) and platelet counts at 3, 6, 9 and 12 months after PBSCT, were studied in 25 patients with haematological and solid malignancies. The total CD34+ cell number, as well as CD34+/CD90+ and CD34+/AC133+ cell numbers, correlated with platelet counts at 3, 6, 9 and 12 months after PBSCT, but the CD34+/CD90+ cells infused best predicted platelet recovery during the first 12 months after PBSCT (P < 0.0238 at any time-point). The CD34+/AC133+ cell dose also correlated with WBC counts at 3 months post PBSCT. In addition, all patients receiving more than 80 x 10(4) CD34+/CD90+ cells/kg showed platelet counts greater than 100 x 10(9)/l at all points after PBSCT, suggesting that this value of the CD34+/CD90+ cells infused was a threshold dose for durable haematopoietic engraftment after PBSCT.
References
Apr 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·C M BaumB Peault
Jan 1, 1994·Clinical Immunology and Immunopathology·J G BenderD E Van Epps
Aug 1, 1994·British Journal of Haematology·W I BensingerJ Klarnet
Aug 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M W DercksenC E van der Schoot
May 1, 1993·The Journal of Experimental Medicine·W CraigP M Lansdorp
Nov 1, 1994·Bone·S NishidaH E Takahashi
Feb 2, 1997·Bone Marrow Transplantation·J E KissE D Ball
Jun 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A L PecoraJ A Brochstein
Jul 23, 1998·Bone Marrow Transplantation·R FengM Nakagawa
Sep 11, 1998·Bone Marrow Transplantation·B C MillarD Catovsky
Nov 25, 1998·British Journal of Haematology·P HénonD Bouderont
Dec 19, 1998·British Journal of Haematology·L PereyS Leyvraz
Jul 22, 1999·Bone Marrow Transplantation·D A StewartJ A Russell
Aug 24, 1999·Bone Marrow Transplantation·M L AmigoJ F San Miguel
Jan 11, 2000·Bone Marrow Transplantation·J A Pérez-SimónJ F San Miguel
Mar 21, 2000·Bone Marrow Transplantation·D A StewartS Gluck
Jul 25, 2000·Experimental Hematology·M MichalletE Archimbaud
Feb 27, 2001·Bone Marrow Transplantation·P R DugganD A Stewart
Citations
Dec 6, 2011·Bone Marrow Transplantation·M Beksac, F Preffer
Nov 23, 2006·Acta Haematologica·Giorgina SpecchiaVincenzo Liso
Jan 24, 2009·The Journal of Clinical Investigation·Amy P WongThomas K Waddell
May 27, 2004·Leukemia & Lymphoma·Chihiro ShimazakiTohru Inaba
Apr 17, 2007·Experimental Cell Research·Ian RogersRobert F Casper
Apr 3, 2004·British Journal of Haematology·Francesco BuccisanoValter Gattei
Nov 7, 2008·Journal of Clinical Apheresis·Akira OkanoMasafumi Taniwaki
Aug 23, 2006·Cytotherapy·A C ZubairJ Ritz
Dec 21, 2013·Cytotechnology·S IndumathiM Dhanasekaran
Oct 1, 2016·Journal of Hematology & Oncology·Yulin XuHe Huang
Dec 14, 2011·Leukemia·J J W M JanssenG J Ossenkoppele
May 9, 2006·American Journal of Hematology·Aurea CerveraJosé L Vicario
May 23, 2003·American Journal of Clinical Pathology·Anthony ChangSteven J Kussick
Nov 4, 2005·Cancer Research·Rebecca G BagleyBeverly A Teicher
Apr 7, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shifra AshSmadar Avigad
Feb 11, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kieuhoa T VoSteven G Dubois
May 24, 2021·Cytotherapy·Christoph SchanielRonald Hoffman
Nov 13, 2004·Stem Cells·Tai-Wei David LeongDietmar Werner Hutmacher